Comments
Zydus Cadila today said it has got a final nod from the US Food and Drug Administration (USFDA) for marketing Omeprazole and Sodium bicarbonate capsules, used for treating stomach and oesophagus problems such as ulcers. The drug will be manufactured at the group’s formulation manufacturing unit in Ahmedabad.
“Zydus Cadila has received the final approval from USFDA to market Omeprazole and sodium bicarbonate capsules 20 mg/1100 mg (OTC),” the company said in a filing to BSE. The drug is also used for preventing stomach bleeding in very ill patents, it said. The group now has more than 180 approvals and has so far filed over 320 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04. The company, a global pharmaceutical firm, employs over 21,000 people worldwide.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.